The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen.
I García-Sáez, D Reverter, J Vendrell, F X Avilés, M Coll
文献索引:EMBO J. 16(23) , 6906-13, (1997)
全文:HTML全文
摘要
The three-dimensional structure of human procarboxypeptidase A2 has been determined using X-ray crystallography at 1.8 A resolution. This is the first detailed structural report of a human pancreatic carboxypeptidase and of its zymogen. Human procarboxypeptidase A2 is formed by a pro-segment of 96 residues, which inhibits the enzyme, and a carboxypeptidase moiety of 305 residues. The pro-enzyme maintains the general fold when compared with other non-human counterparts. The globular part of the pro-segment docks into the enzyme moiety and shields the S2-S4 substrate binding sites, promoting inhibition. Interestingly, important differences are found in the pro-segment which allow the identification of the structural determinants of the diverse activation behaviours of procarboxypeptidases A1, B and A2, particularly of the latter. The benzylsuccinic inhibitor is able to diffuse into the active site of procarboxypeptidase A2 in the crystals. The structure of the zymogen-inhibitor complex has been solved at 2.2 A resolution. The inhibitor enters the active site through a channel formed at the interface between the pro-segment and the enzyme regions and interacts with important elements of the active site. The derived structural features explain the intrinsic activity of A1/A2 pro-enzymes for small substrates.
相关化合物
相关文献:
1996-03-01
[J. Cell. Biochem. 60(3) , 424-36, (1996)]
2011-01-01
[PLoS ONE 6(4) , e19270, (2011)]
1989-07-01
[Gastroenterology 97(1) , 61-7, (1989)]
2009-05-01
[Yao Xue Xue Bao 44(5) , 491-5, (2009)]
2009-01-01
[Congest. Heart Fail. 15(1) , 49, (2009)]